The forensic architecture of Wells Fargo’s 2025 regulatory failures is not merely a repetition of the 2016 fake account scandal. It is an evolution. The bank moved from directly opening unauthorized accounts to becoming the silent infrastructure for third-party predation. This section dissects the specific mechanics of the "Free Sample" scheme and the unauthorized enrollment engines that triggered the $33 million class-action settlement finalized in late 2025. This scandal exposes a critical lapse in the bank's merchant monitoring protocols and a blatant disregard for the 2018 and 2024 consent orders.

The core of the 2025 unauthorized subscription scandal lies in Wells Fargo’s relationship with a network of shadowy merchant entities identified in court filings as the Apex, Triangle, and Tarr companies. These entities operated a sophisticated "negative option billing" scheme. The mechanism was clinically efficient. Consumers were targeted with digital advertisements for "free trials" of personal care products. These included keto diet pills. They included skin creams. They included electronic cigarettes.